National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, USA.
PLoS One. 2010 Sep 7;5(9):e12579. doi: 10.1371/journal.pone.0012579.
Purification of recombinant membrane receptors is commonly achieved by use of an affinity tag followed by an additional chromatography step if required. This second step may exploit specific receptor properties such as ligand binding. However, the effects of multiple purification steps on protein yield and integrity are often poorly documented. We have previously reported a robust two-step purification procedure for the recombinant rat neurotensin receptor NTS1 to give milligram quantities of functional receptor protein. First, histidine-tagged receptors are enriched by immobilized metal affinity chromatography using Ni-NTA resin. Second, remaining contaminants in the Ni-NTA column eluate are removed by use of a subsequent neurotensin column yielding pure NTS1. Whilst the neurotensin column eluate contained functional receptor protein, we observed in the neurotensin column flow-through misfolded NTS1.
To investigate the origin of the misfolded receptors, we estimated the amount of functional and misfolded NTS1 at each purification step by radio-ligand binding, densitometry of Coomassie stained SDS-gels, and protein content determination. First, we observed that correctly folded NTS1 suffers damage by exposure to detergent and various buffer compositions as seen by the loss of [(3)H]neurotensin binding over time. Second, exposure to the neurotensin affinity resin generated additional misfolded receptor protein.
Our data point towards two ways by which misfolded NTS1 may be generated: Damage by exposure to buffer components and by close contact of the receptor to the neurotensin affinity resin. Because NTS1 in detergent solution is stabilized by neurotensin, we speculate that the occurrence of aggregated receptor after contact with the neurotensin resin is the consequence of perturbations in the detergent belt surrounding the NTS1 transmembrane core. Both effects reduce the yield of functional receptor protein.
重组膜受体的纯化通常通过使用亲和标签来实现,如果需要,还可以进行额外的色谱步骤。第二步可以利用受体的一些特定性质,如配体结合。然而,多个纯化步骤对蛋白质产量和完整性的影响往往记录不佳。我们之前报道了一种稳健的两步纯化程序,用于纯化重组大鼠神经降压素受体 NTS1,可获得毫克量的功能受体蛋白。首先,使用 Ni-NTA 树脂通过固定化金属亲和层析富集组氨酸标记的受体。其次,通过使用随后的神经降压素柱去除 Ni-NTA 柱洗脱液中的残留污染物,得到纯 NTS1。虽然神经降压素柱洗脱液含有功能性受体蛋白,但我们在神经降压素柱流通过程中观察到错误折叠的 NTS1。
为了研究错误折叠受体的起源,我们通过放射性配体结合、考马斯亮蓝染色 SDS-凝胶的密度测定和蛋白质含量测定来估计每个纯化步骤中功能性和错误折叠的 NTS1 的量。首先,我们观察到正确折叠的 NTS1 会因暴露于去污剂和各种缓冲液组成而受到损伤,表现为[(3)H]神经降压素结合随时间的损失。其次,暴露于神经降压素亲和树脂会产生额外的错误折叠受体蛋白。
我们的数据表明错误折叠的 NTS1 可能有两种产生方式:暴露于缓冲成分和受体与神经降压素亲和树脂的紧密接触。由于神经降压素溶液中的 NTS1 被神经降压素稳定,我们推测与神经降压素树脂接触后受体聚集的发生是由于围绕 NTS1 跨膜核心的去污剂带的扰动所致。这两种效应都会降低功能性受体蛋白的产量。